0001493152-24-015877.txt : 20240425 0001493152-24-015877.hdr.sgml : 20240425 20240425113644 ACCESSION NUMBER: 0001493152-24-015877 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240422 FILED AS OF DATE: 20240425 DATE AS OF CHANGE: 20240425 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CZIRR JAMES C CENTRAL INDEX KEY: 0001260641 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31791 FILM NUMBER: 24874100 MAIL ADDRESS: STREET 1: 4908 SOUTH ASHTON COURT CITY: SPOKANE STATE: WA ZIP: 99223 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GALECTIN THERAPEUTICS INC CENTRAL INDEX KEY: 0001133416 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 043562325 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD STREET 2: SUITE 240 CITY: NORCROSS STATE: GA ZIP: 30071 BUSINESS PHONE: 678-620-3186 MAIL ADDRESS: STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD STREET 2: SUITE 240 CITY: NORCROSS STATE: GA ZIP: 30071 FORMER COMPANY: FORMER CONFORMED NAME: PRO PHARMACEUTICALS INC DATE OF NAME CHANGE: 20010612 4 1 ownership.xml X0508 4 2024-04-22 0 0001133416 GALECTIN THERAPEUTICS INC GALT 0001260641 CZIRR JAMES C 4908 S. ASHTON CT. SPOKANE, WA 99223 0 0 1 0 0 Common Stock 2024-04-22 4 S 0 21323 3.06 D 5925884 I By 10X Fund, LP Common Stock 2024-04-23 4 S 0 3677 3.06 D 5922207 I By 10X Fund, LP The securities were sold by 10X Fund, LP. James C. Czirr is the manager of 10X Capital Management, LLC, which is the general partner of 10X Fund, L.P., a Delaware limited partnership, and as such Mr. Czirr may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. /s/ James C. Czirr, Individually 2024-04-25